Financings Of The Fortnight Applies Its Own Lens To Early-Stage Investments

 
• By Alex Lash and Amanda Micklus

Plus news on recent financings by Neurocrine Biosciences, Prosensa, RaNA Therapeutics and Trius Therapeutics.

More from Archive

More from Pink Sheet